Successful Cord Blood Transplantation in a Werner Syndrome Patient with High-risk Myelodysplastic Syndrome

被引:5
|
作者
Hayashi, Kiyohito [1 ]
Tasaka, Taizo [1 ,2 ]
Kondo, Toshinori [1 ]
Ishikawa, Yuichi [3 ]
Goto, Makoto [4 ]
Matsuhashi, Yoshiko [1 ]
Sadahira, Yoshito [5 ]
Sugihara, Takashi [1 ]
Wada, Hideho [1 ]
机构
[1] Kawasaki Med Sch, Dept Hematol, Kurashiki, Okayama, Japan
[2] Saitama Med Univ, Saitama Med Ctr, Dept Transfus Med, Saitama, Japan
[3] Japanese Fdn Canc Res, Canc Inst, Dept Pathol, Ariake, Japan
[4] Tokyo Womens Med Univ, East Med Ctr, Dept Rheumatol Orthoped Surg, Tokyo, Japan
[5] Kawasaki Med Sch, Dept Pathol, Kurashiki, Okayama, Japan
关键词
Werner syndrome; myelodysplastic syndrome; cord blood transplantation; CELL TRANSPLANTATION; BUSULFAN; FLUDARABINE; MELPHALAN; SPECTRUM; REGIMEN;
D O I
10.2169/internalmedicine.0317-17
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Werner syndrome (WS) confers a high risk of the development of neoplasias, including hematological malignancies, and curative treatment for these malignancies is difficult to achieve. A 44-year-old man with myelodysplastic syndrome was admitted to our hospital. He was diagnosed with mutation-proven WS. He underwent cord blood transplantation (CBT) following fludarabine, busulfan, and melphalan administration. A chimerism analysis of his marrow blood on day 62 showed a donor pattern >95%, which confirmed engraftment. The patient lived for 15 months while maintaining remission of MDS without treatment-related toxicity. Our case shows that CBT can be a treatment modality for WS patients with hematological malignancies.
引用
收藏
页码:109 / 113
页数:5
相关论文
共 50 条
  • [41] CORONARY ARTERY BYPASS GRAFTING IN HIGH-RISK MYELODYSPLASTIC SYNDROME
    Zhang, Kathleen
    Wiesehan, Holly
    Westervelt, Peter
    Maniar, Hersh
    Krone, Ronald
    Lenihan, Daniel
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 2688 - 2688
  • [42] Novel therapies in low- and high-risk myelodysplastic syndrome
    Germing, Ulrich
    Schroeder, Thomas
    Kaivers, Jennifer
    Kuendgen, Andrea
    Kobbe, Guido
    Gattermann, Norbert
    EXPERT REVIEW OF HEMATOLOGY, 2019, 12 (10) : 893 - 908
  • [43] Pretransplantation 5-Azacitidine in High-Risk Myelodysplastic Syndrome
    Nishihori, Taiga
    Perkins, Janelle
    Mishra, Asmita
    Komrokji, Rami
    Kim, Jongphil
    Kharfan-Dabaja, Mohamed A.
    Perez, Lia
    Lancet, Jeffrey
    Fernandez, Hugo
    List, Alan
    Anasetti, Claudio
    Field, Teresa
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (06) : 776 - 780
  • [44] Successful Cord Blood Transplantation for Chronic Granulomatosis Disease with McLeod Syndrome
    Goto, Kimitoshi
    Higuchi, Kohei
    Sawada, Akihisa
    Okada, Yosuke
    Sato, Maho
    Yasui, Masahiro
    Inoue, Masami
    PEDIATRIC BLOOD & CANCER, 2020, 67
  • [45] Successful Management of Bouveret's Syndrome With Severe Esophagitis in a High-Risk Surgical Patient
    Pourmorteza, Mohsen
    Rives, Charles
    Pourmorteza, Mehdi
    Litchfield, John
    Mckinney, Jason
    Young, Mark
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S410 - S410
  • [46] Patterns of lower risk myelodysplastic syndrome progression: factors predicting progression to high-risk myelodysplastic syndrome and acute myeloid leukemia
    Jain, Akriti G.
    Ball, Somedeb
    Aguirre, Luis
    Al Ali, Najla
    Kaldas, David
    Tinsley-Vance, Sara
    Kuykendall, Andrew
    Chan, Onyee
    Sweet, Kendra
    Lancet, Jeffrey E.
    Padron, Eric
    Sallman, David A.
    Komrokji, Rami
    REVISTA CHILENA DE LITERATURA, 2024, (109): : 2157 - 2164
  • [47] Patterns of lower risk myelodysplastic syndrome progression: factors predicting progression to high-risk myelodysplastic syndrome and acute myeloid leukemia
    Jain, Akriti G.
    Ball, Somedeb
    Aguirre, Luis
    Al Ali, Najla
    Kaldas, David
    Tinsley-Vance, Sara
    Kuykendall, Andrew
    Chan, Onyee
    Sweet, Kendra
    Lancet, Jeffrey E.
    Padron, Eric
    Sallman, David A.
    Komrokji, Rami
    HAEMATOLOGICA, 2024, 109 (07) : 2157 - 2164
  • [48] Successful cord blood transplantation for Hurler syndrome patient with high-titer neutralizing antibody against α-l-iduronidase
    Hamazaki, Takashi
    Tomita, Kazuyoshi
    Nakaya, Masaharu
    Hamasaki, Arata
    Tachibana, Daisuke
    Tokimasa, Sadao
    Tanaka, Akemi
    Haruo, Shintaku
    MOLECULAR GENETICS AND METABOLISM, 2015, 114 (02) : S50 - S50
  • [49] HIGH RISK MYELODYSPLASTIC SYNDROME
    Sanchez-Calero Guilarte, J.
    Ayala, R.
    LEUKEMIA RESEARCH, 2017, 55 : S177 - S179
  • [50] High Risk Myelodysplastic Syndrome
    Dahmaoui, Nizar
    Lamchahab, Mouna
    Douma, Soukaina
    Fatih, Basma
    Oukkach, Bouchra
    Rachid, Mohamed
    Qachouh, Meryem
    Cherkaoui, Siham
    Khoubila, Nissrine
    Madani, Abdellah
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S312 - S312